Adverse events663

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 663

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anaemia	Blood and lymphatic system disorders	Tislelizumab + Paclitaxel + Carboplatin	107	120	277
other	Anaemia	Blood and lymphatic system disorders	Tislelizumab + Nab-Paclitaxel + Carboplatin	111	118	297
other	Anaemia	Blood and lymphatic system disorders	Paclitaxel + Carboplatin	94	117	198
other	Leukocytosis	Blood and lymphatic system disorders	Tislelizumab + Paclitaxel + Carboplatin	3	120	4
other	Leukocytosis	Blood and lymphatic system disorders	Tislelizumab + Nab-Paclitaxel + Carboplatin	4	118	5
other	Leukocytosis	Blood and lymphatic system disorders	Paclitaxel + Carboplatin	7	117	11
other	Leukopenia	Blood and lymphatic system disorders	Tislelizumab + Paclitaxel + Carboplatin	58	120	234
other	Leukopenia	Blood and lymphatic system disorders	Tislelizumab + Nab-Paclitaxel + Carboplatin	66	118	291
other	Leukopenia	Blood and lymphatic system disorders	Paclitaxel + Carboplatin	57	117	187
other	Neutropenia	Blood and lymphatic system disorders	Tislelizumab + Paclitaxel + Carboplatin	53	120	191
other	Neutropenia	Blood and lymphatic system disorders	Tislelizumab + Nab-Paclitaxel + Carboplatin	50	118	196
other	Neutropenia	Blood and lymphatic system disorders	Paclitaxel + Carboplatin	56	117	160
other	Thrombocytopenia	Blood and lymphatic system disorders	Tislelizumab + Paclitaxel + Carboplatin	36	120	89
other	Thrombocytopenia	Blood and lymphatic system disorders	Tislelizumab + Nab-Paclitaxel + Carboplatin	48	118	131
other	Thrombocytopenia	Blood and lymphatic system disorders	Paclitaxel + Carboplatin	33	117	54
other	Sinus bradycardia	Cardiac disorders	Tislelizumab + Paclitaxel + Carboplatin	2	120	6
other	Sinus bradycardia	Cardiac disorders	Tislelizumab + Nab-Paclitaxel + Carboplatin	5	118	12
other	Sinus bradycardia	Cardiac disorders	Paclitaxel + Carboplatin	0	117	0
other	Supraventricular extrasystoles	Cardiac disorders	Tislelizumab + Paclitaxel + Carboplatin	4	120	4
other	Supraventricular extrasystoles	Cardiac disorders	Tislelizumab + Nab-Paclitaxel + Carboplatin	5	118	14

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03594747/events

API reference For AI assistants

Adverse events663

Sources 3

Read this list from software.